|
|
| Informed Consent Isn't Broken — But It's Barely Working | From The Editor | By Dan Schell, chief editor, Clinical Leader | Former FDA Commissioner Dr. Robert Califf has been blunt about what’s wrong with informed consent in clinical trials. This article offers a high-level look at his three-part Substack series, exploring how consent became more about legal protection than patient understanding — and what needs to change. |
|
|
|
|
|
|
| Critical Supply Strategies For CROs | White Paper | Catalent | Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy. |
|
|
| Phase 1 Trial In Painful Diabetic Peripheral Neuropathy | Case Study | Flourish Research | A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution. |
|
|
| End-To-End Biostatistics In Clinical Research | Product | Worldwide Flex | Optimize your clinical trials with end-to-end biostatistics and innovative trial designs. Your trial will benefit from submission-ready data, modern safety tech, and scalable, cost-effective FSP. |
|
|
|
|
| Why We Need To Look To The Future Of Clinical Trials | Article | MRN - Medical Research Network | Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency. |
|
|
| Connect With Clinical Leader: |
|
|
|
